Taking into advance the ability of A2A adenosine receptor to offer protection against retinal inflammation in diabetic retinopathy, the use of the A2A adenosine receptor agonist CGS21680 in other ocular retinal pathologies in which proinflammatory mediators are released has also been examined [55]. The gene discussed is ADORA2A; the disease is diabetic retinopathy.